AzTrials
AzTrials

Respiratory Distress SyndromeNCT06549283

Nasal Intermittent Positive Pressure Ventilation During Neonatal Intubation

A study testing Nasal intermittent positive pressure ventilation (NIPPV) via binasal cannula during neonatal intubation in people with Respiratory Distress Syndrome and Intubation; Difficult or Failed, run by Muğla Sıtkı Koçman University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increases the rate of successful intubation without physiological instability during all intubation attempts. Read more about this study

Who is it for?
Ages 1 day to 28 days
What is being tested?
Nasal intermittent positive pressure ventilation (NIPPV) via binasal cannula during neonatal intubation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
146 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 May 2023to 15 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants of a gestational age of 22-41 weeks and undergoing oral endotracheal intubation in the neonatal intensive care within the first 28 days of life

Who cannot join

  • The infants who required urgent intubation,
  • Infants intubated in the delivery room or the operating room,
  • Infants with a heart rate of <120/min prior to randomization,
  • Infants with airway or lung anomalies,
  • Infants with cyanotic congenital heart disease,
  • Infants NIPPV treatment was contraindicated (congenital nasal anomaly, congenital diaphragmatic hernia, or abdominal wall defect)

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Akdeniz University School of Medicine, Department of Neonatology

    Antalya, 07000

  • Mugla Training and Research Hospital, Department of Neonatology

    Menteşe, Muğla, 48000

Other trials in Turkey (Türkiye)

About this study

Official title: Nasal Intermittent Positive Pressure Ventilation (NIPPV) During Neonatal Endotracheal Intubation: A Randomized Controlled Trial

The study aims to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increases the rate of successful intubation without physiological instability during all intubation attempts.

The present study was designed as a prospective, multicenter, randomized, controlled study conducted with neonates undergoing endotracheal intubation. The infants were assigned randomly to either the NIPPV group or the standard care group.

Read the detailed description

The present study was designed as a prospective, multicenter, randomized, controlled trial. The study was conducted at two tertiary Neonatal Intensive Care Units (Mugla Training and Research Hospital, Mugla, Turkey; Akdeniz University School of Medicine, Antalya, Turkey) between May 2023 and May 2024. Written informed consent was obtained from the parents of each neonatal patient prior to enrollment in the study.

Participants:

Infants of a gestational age of 22-41 weeks and undergoing oral endotracheal intubation in the neonatal intensive care unit within the first 28 days of life were eligible for inclusion in the present study. The infants who required urgent intubation, those intubated in the delivery room or the operating room, infants with a heart rate of <120/min prior to randomization, those with airway or lung anomalies, the ones with cyanotic congenital heart disease, and the ones for whom nasal intermittent positive pressure ventilation (NIPPV) treatment was contraindicated (congenital nasal anomaly, congenital diaphragmatic hernia, or abdominal wall defect) were excluded from the study.

Randomization:

Each infant was randomly assigned to either the intervention group or the standard-care group. Sequential numbers were generated in the neonatal intensive care unit's computer with an allocation ratio of 1:1. The numbers were concealed in opaque, sequentially numbered, sealed envelopes. The physician on call opened sequentially numbered sealed opaque envelopes and randomized infants to respective groups before procedure.

Definitions:

An attempt was defined as an airway maneuver, which commenced with the insertion of the laryngoscope blade (conventional) into the mouth of the patient and ended with the removal of the blade. Successful airway management was defined as the placement of an endotracheal tube in the trachea, confirmed based on chest elevation, auscultation, second independent laryngoscopy, carbon dioxide detection, and/or chest radiography. First-attempt success was defined as successful intubation by the first practitioner on the first attempt. Multiple-attempt success was defined as the requirement of over two attempts (≥3) for successful intubation. The requirement for single, two, or multiple attempts for successful intubation was defined as all intubation attempts. Severe oxygen desaturation during intubation was defined as a decrease of ≥20% in oxygen saturation relative to the highest level of oxygen saturation recorded prior to the first attempt. Bradycardia was defined as a heart rate of <100 beats per minute. Physiological instability was defined as severe desaturation (a decrease of >20% in oxygen saturation relative to that immediately prior to pre-laryngoscopy) or bradycardia (a heart rate of <100 beats per minute) during the intubation attempts.

Interventions:

All neonates were monitored using a Philips monitor (IntelliVue MX450) that displayed the real-time peripheral oxygen saturation (SpO2) and heart rate prior to, during, and after the procedure. The patients were divided into two groups: the NIPPV group and the standard care group. In the NIPPV group, NIPPV was implemented during the entire intubation process (pre-intubation to intubation to the end of successful intubation). Appropriately-sized bi-nasal cannulae (Optiflow Junior, Fisher and Paykel, Auckland, New Zealand) were placed prior to laryngoscopy as interface for NIPPV implementation. NIPPV was implemented using Drager Babylog 8000 (Draeger Medicals Inc., Lubeck, Germany) or Leoni Plus (Löwenstein Medical, Bad Ems, Germany) mechanical ventilator. Non-synchronized NIPPV was implemented. NIPPV was initiated prior to intubation, with the peak inspiratory pressure set to 16-20 cmH2O (selected according to the infant's birth weight and chest wall expansion), positive-end expiratory pressure set to 6 cmH2O, breathing rate set to 40-50 breaths/min, inspiratory time set to 0.40-0.45 s, and flow rate set to 8-12 L/min. After the first successful intubation attempt, NIPPV was discontinued. Prior to laryngoscopy, the fraction of inspired oxygen (FiO2) was adjusted to maintain SpO2 above 90%. In the standard care group, the intubation attempt proceeded without NIPPV or supplemental oxygen. In the event of failure in the intubation attempt, SpO2 was increased above 90%, and the heart rate was increased above 120/min by applying positive pressure ventilation using a face mask prior to initiating the next intubation procedure. The size of the intubation tube was determined based on the baby's body weight [12]. Stylet was not used during intubation. Endotracheal intubations were performed either by pediatric research assistants or a neonatologist. A conventional laryngoscope with a straight blade was used for the intubation. Video laryngoscope was not used. Data accuracy was ensured by videotaping the monitor-displayed heart rate and SpO2 during the intubation procedure. After intubation, an independent assessor who was not part of the intubation team reviewed all recorded videos to document the obtained data on a case report form.

Data collection and management:

Data for demographic and clinical characteristics were collected for all patients. A pre-assigned staff member who was not a part of the intubation team noted the vital signs, adverse outcomes, and complications during and after the procedure and also collected blood gas one hour after the intubation for each patient.

Trial outcomes:

The primary outcome was successful intubation without physiological instability during all intubation attempts in the neonate. The secondary outcome was the lowest SpO2 level, lowest heart rate, bradycardia, severe desaturation, duration of severe desaturation, successful intubation on the first attempt without physiological instability, and time to successful intubation.

Sample size:

Hodgson et al. reported that the rate of successful intubation on the first attempt without physiological instability was 31% in newborns who did not receive additional respiratory support during intubation. In the present study, it was hypothesized that the success rate of intubation on the first attempt without physiological instability would increase from 31% to 54% upon the implementation of NIPPV during intubation. The sample size was calculated using the "G*Power 3.1.9.4" program with a type I error of 5% level and a power of 80%. Accordingly, it was concluded that 75 intubation episodes were required for each group, and 150 intubation episodes were required in total.

Statistical analysis:

Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) software (version 25; Armonk, NY: IBM Corp.). The Kolmogorov-Smirnov and Shapiro-Wilk tests were conducted to determine the normal distribution of data. Student's t-test was conducted to compare the continuous parametric variables. The Mann-Whitney U-test was conducted to compare variables with non-normal distribution. Chi-squared or Fisher's exact test was conducted to analyze the categorical variables. Categorical variables were expressed as numbers (%). Normally distributed variables were expressed as mean ± standard deviation values. Non-parametric continuous variables were expressed as median values (interquartile range). The difference with p < 0.05 was considered statistically significant.

Being tested
Nasal intermittent positive pressure ventilation (NIPPV) via binasal cannula during neonatal intubation
Medical subject headings
Respiratory Distress Syndrome, Bronchopulmonary Dysplasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nasal intermittent positive pressure ventilation (NIPPV) via binasal cannula during neonatal intubationDevice

    Researchers applied NIPPV treatment using binasal cannulas through a mechanical ventilator during intubation.

Study groups in NCT06549283
Study groupRoleWhat they receive
NIPPV groupActive comparatorNasal intermittent positive pressure ventilation (NIPPV) was implemented during the entire intubation process (pre-intubation to intubation to the end of successful intubation). Appropriately-sized bi-nasal cannulae were placed prior to laryngoscopy as interface for NIPPV implementation. Non-synchronized NIPPV was implemented. NIPPV was initiated prior to intubation, with the peak inspiratory pressure set to 16-20 cmH2O (selected according to the infant's birth weight and chest wall expansion), positive-end expiratory pressure set to 6 cmH2O, breathing rate set to 40-50 breaths/min, inspiratory time set to 0.40-0.45 s, and flow rate set to 8-12 L/min. After the first successful intubation attempt, NIPPV was discontinued. Prior to laryngoscopy, the fraction of inspired oxygen (FiO2) was adjusted to maintain SpO2 above 90%.
Receives: Device: Nasal intermittent positive pressure ventilation (NIPPV) via binasal cannula during neonatal intubation
Standard-care groupNo interventionThe intubation attempt proceeded without NIPPV or supplemental oxygen.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Successful intubation without physiological instability during all intubation attempts

    Successful intubation was defined as the placement of an endotracheal tube in the trachea, confirmed based on chest elevation, auscultation, second independent laryngoscopy, carbon dioxide detection, and/or chest radiography.

    Physiological instability was defined as severe desaturation (a decrease of >20% in oxygen saturation relative to that immediately prior to pre-laryngoscopy) or bradycardia (a heart rate of <100 beats per minute) during the intubation attempts.

    All intubation attempts was defined as the requirement for single, two, or multiple attempts for successful intubation.

    Measured: One year

Secondary outcomes (7)
  1. Lowest SpO2 level

    Lowest peripheral oxygen saturation level during intubation

    Measured: One year

  2. Lowest heart rate

    Lowest heart rate during intubation

    Measured: One year

  3. Bradycardia

    Bradycardia was defined as a heart rate of <100 beats per minute

    Measured: One year

  4. Severe desaturation

    Severe desaturation was defined as a decrease of ≥20% in oxygen saturation relative to the highest level of oxygen saturation recorded prior to the first attempt

    Measured: One year

  5. Successful intubation on the first attempt without physiological instability

    Successful intubation was defined as the placement of an endotracheal tube in the trachea, confirmed based on chest elevation, auscultation, second independent laryngoscopy, carbon dioxide detection, and/or chest radiography.

    Physiological instability was defined as severe desaturation (a decrease of >20% in oxygen saturation relative to that immediately prior to pre-laryngoscopy) or bradycardia (a heart rate of <100 beats per minute) during the intubation attempts.

    Measured: One year

  6. Time to successful intubation

    Time until successful intubation is achieved. Successful intubation was defined as the placement of an endotracheal tube in the trachea, confirmed based on chest elevation, auscultation, second independent laryngoscopy, carbon dioxide detection, and/or chest radiography.

    Measured: One year

  7. Duration of severe desaturation

    Duration of severe desaturation during intubation attempts. Severe desaturation was defined as a decrease of ≥20% in oxygen saturation relative to the highest level of oxygen saturation recorded prior to the first attempt

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2024
  2. Study start1 May 2023
  3. Primary completion1 May 2024
  4. Study completion15 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The patients were divided into two groups: the NIPPV group and the standard care group. In the NIPPV group, NIPPV was implemented during the entire intubation process (pre-intubation to intubation to the end of successful intubation). In the standard care group, the intubation attempt proceeded without NIPPV or supplemental oxygen.
Masking
None (open label)
Enrolment
146 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06549283
Sponsor's protocol ID
MSKU-NICU-OI-01
Status last verified
Aug 2024
First submitted
8 Aug 2024
Last updated
12 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Our data is available upon request, and we are committed to providing access to interested researchers for the purpose of scientific inquiry.

Questions about this trial

What is this clinical trial studying?

A study testing Nasal intermittent positive pressure ventilation (NIPPV) via binasal cannula during neonatal intubation in people with Respiratory Distress Syndrome and Intubation; Difficult or Failed, run by Muğla Sıtkı Koçman University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Successful intubation without physiological instability during all intubation attempts (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in